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Background: It has been proposed that physical exercise can help improve upper limb
functions in Parkinson’s disease (PD) patients; yet evidence for this hypothesis is limited.
Objective: To assess the effects of aerobic exercise training (AET) on general upper
limb functions in sedentary people with PD and healthy adults (HA).
Methods: Two groups, 19 PD patients (Hoehn & Yahr ≤ 2) and 20 HA, matched
on age and sedentary level, followed a 3-month stationary bicycle AET regimen. We
used the kinematic theory framework to characterize and quantify the different motor
control commands involved in performing simple upper-limb movements as drawing
lines. Repeated measures ANCOVA models were used to assess the effect of AET in
each group, as well as the difference between groups following the training regimen.
Results: At baseline, PD individuals had a larger antagonist response, a longer elapsed
time between the visual stimulus and the end of the movement, and a longer time of
displacement of the stylus than the HA. Following the 12-week AET, PD participants
showed significant decreases of the agonist and antagonist commands, as well
as the antagonist response spread. A significant group ∗ session interaction effect
was observed for the agonist command and the response spread of the antagonist
command, suggesting a significant change for these two parameters only in PD patients
following the AET. Among the differences observed at baseline, only the difference for
the time of movement remained after AET.
Conclusion: A 3-month AET has a significant positive impact on the capacity to draw
lines in a more efficiency way, in PD patients, indicating an improvement in the upper
limb motor function.
Keywords: Parkinson’s disease, exercise, upper limb function, aerobic, stationary bicycle
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INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative condition
characterized by cardinal motor symptoms, such as tremor,
rigidity, and bradykinesia (Goetz et al., 2008). These symptoms
impact the movement and function of the upper limbs during
everyday activities such as writing, self-care, and fine object
manipulation. Past studies have also shown that PD patients
present difficulties in force control, as well as in coordinating
and controlling multiple tasks (Alberts et al., 1998). For example,
they are impaired in modulating muscles activity, as reflected
by an antagonist activation occurring earlier than normal,
hence overlapping with actions from the agonist muscle (Pfann
et al., 2001). Such disease-related functional alterations may
thus explain the difficulties observed in fine motor skills and
general upper movements in PD, hence leading to restrictions in
autonomy and quality of life.
Parkinson’s disease is usually treated using medication
(levodopa, dopamine agonists) and surgical intervention (deep
brain stimulation). While these treatments are very effective upon
initiation, their effectiveness diminishes over time and a range
of side effects emerges. Physical exercise has been proposed as
an adjuvant therapy and a complementary approach that could
improve both motor and non-motor symptoms in PD (Goodwin
et al., 2008; Speelman et al., 2011). Among the motor benefits,
a few studies have suggested that exercise could be a good
alternative intervention to improve upper limb function (Ridgel
et al., 2009, 2012; Muller and Muhlack, 2010; Alberts et al.,
2011). However, it is imperative to understand the mechanisms
underlying its therapeutic impacts. In addition, the present
study intends to investigate the association between upper limb
function and other domains such as executive functioning and
motor sequence learning (MSL) known to be impaired in PD
patients and sensitive physical exercise.
To date, several studies have aimed to better understand the
role of exercise on neurophysiological mechanisms regulating
upper limb functions in PD population (Ridgel et al., 2009;
Alberts et al., 2011; David et al., 2016). In Alberts et al. (2011),
the Opening Container Task was used in PD participants before
and after an 8-week forced exercise (FE) intervention that used
a lower limb tandem cycling apparatus (Alberts et al., 2011).
In comparison to a voluntary exercise (VE) group, the FE
group showed an improvement in grip-load coupling and an
increased rate of grip force production. The authors concluded
that such training modality could be efficient in improving
global motor functioning in people with PD. However, the
specific mechanisms underlying such improvements are still
unknown. In another study, David et al. (2016) showed that
not only a 24-month of progressive resistance exercise did
result in faster elbow movement velocity in PD participants,
but also that such exercising program led to a normalized
magnitude of agonist burst and an increased antagonist muscle
activity, as measured with electromyography (EMG) (David et al.,
2016).
The efficacy of exercise in improving upper limb functions
in PD cannot be properly assessed unless we use appropriate
and specific measurements of this function. To date, several
tests have been developed to assess fine upper limb functioning.
For instance, tasks requiring object manipulation, such as coin
flipping or spinning, changing a combination lock, transferring
small objects from point A to point B (Stewart et al., 2009),
simple tapping tasks, or the Purdue pegboard test, have all been
used to measure motoric functions in PD patients (Alberts et al.,
2011). Even tasks simulating real-life activities, such as opening
a container, have been tested (Alberts et al., 2011) and shown to
be sensitive to coordination and motor control problems seen in
PD patients, hence being a good indicator of the global upper
limb function in this clinical population. Yet, these motor tasks
focus mostly on speed of execution, and few of them actually
assess the underlying neurophysiological mechanisms mediating
motor functioning in this population. An ideal test would allow
the characterization of the temporal activation pattern of muscles
during a task involving the upper limb (David et al., 2016),
such as EMG. However, this technique is not user-friendly in
clinical settings as it requires EMG expertise and significant time
to install electrodes on the different muscle groups required to
carry out the array of motor tasks needed to measure motoric
functions in PD.
In this paper, we sought to test whether an aerobic exercise
training (AET) regimen could bring similar improvements on
upper limb motor control using another movement velocity task,
a line drawing task, and whether the effects of AET on the
neurophysiological level could be inferred using the kinematic
theory of human movements. This theory offers an alternative
way to indirectly characterize and quantify the different motor
control commands involved in performing simple upper-limb
movements (Plamondon, 1995a,b, 1998; Plamondon and Alimi,
1997; Feng and Plamondon, 2003; Plamondon et al., 2003; Djioua
and Plamondon, 2008). According to this model, the very large
number of coupled neural and muscular cells constituting a
given neuromuscular network generate an impulse response that
converge toward a lognormal profile. The central nervous system
(CNS) then takes advantage of this emerging behavior in order
to control the velocity of an end effector in simple and complex
tasks.
Figure 1C illustrates, for example, how the Kinematic Theory
describes a rapid pointing movement. Such a movement requires
the activation of an agonist and an antagonist neuromuscular
systems. Each of these systems is thought to produce a lognormal
velocity profile, an asymetric bellshaped curve (solid line, agonist
and dotted line, antagonist in Figure 1C) and the resulting
velocity is the subtraction of these two curves, as depicted in
Figure 1B, which is refered to as a delta-lognormal curve. Each
delta-lognormal equation is described by seven parameters: t0,
the time occurrence of the two input commands activating
the pair of neuromuscular systems; D1 and D2, the agonist
and antagonist commands; µ1 and µ2, the time delay of the
agonist and antagonist systems (on a logarithmic scale); and
σ1 and σ2, the time response of the agonist and antagonist
systems (on a logarithmic scale). In other word, t0, D1, and
D2 describe the central action plan and µ1, µ2, σ1, and σ2
the timing properties of the peripheral synergy reacting to
it. Thus, according to the kinematic theory, the experimental
delta-lognormal velocity profile (Figure 1B) can be used to
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FIGURE 1 | Description of the target directed fast simple RT task. (A) Tablet display and target zone. (B) Speed curve obtained for each line drawn. (C) Kinematic
parameters (t0, time occurrence of the input commands to the neuromuscular system; D1, agonist component; µ1, time delay of D1; σ1, response spread of D1; D2,
antagonist component; µ2, time delay of D2; σ2, response spread of D2; ET, time between visual stimulus and the immobilization of the stylus; RT, reaction time; MT,
movement time).
reconstruct the given movement with its corresponding agonist
and antagonist components, the seven parameters estimated
during the reconstruction process allowing researchers to
indirectly infer the properties of the central controller and the
agonist and antagonist peripheral systems involved in such a
movement.
The lognormality of the asymmetric bellshaped velocity profile
has been validated in many comparative studies and under
numerous experimental conditions (Plamondon et al., 1993;
Djioua and Plamondon, 2008; Woch et al., 2011; O’Reilly et al.,
2013). Moreover, it has even been mathematically demonstrated
that the lognormal profile was the optimal output that a perfectly
controlled neuromuscular system could produce (Djioua and
Plamondon, 2010), and the basic hypotheses of this model
have also been supported using electroencephalography (EEG)
(O’Reilly et al., 2013) and EMG (Plamondon et al., 2013a)
experiments, which have confirmed its physiological plausibility.
Indeed it has been shown, using EEG, that a specific motor
event-related potential (ERP) was happening at t0, the time
occurrence of the neuromuscular commands, as predicted by the
theory (O’Reilly et al., 2013). Additionally, the proportionality of
the cumulative time delays between different muscles involved
in a given movement have also been observed, as expected,
from EMG measurements. Over the years, exploiting lognormal
functions of the synergistic action of neuromuscular networks
in numerous pointing tasks has proven to be a reliable way
to describe the velocity profile of simple human movements
(Plamondon et al., 1993; Plamondon, 1995a,b, 1998; Plamondon
and Alimi, 1997; Djioua and Plamondon, 2008). In doing so,
the parameters extracted in the signal reconstruction provided
a global evaluation, albeit indirect, of a subject fine motricity,
in terms of a central representation of his action plans and the
timing properties of the peripheral processes reacting to it. In
other words, without any EMG or EEG data capturing devices,
the kinematic theory provides a consistent and non-invasive
estimation of the global motor control behavior of a subject.
In response to the knowledge gap described above, the main
objective of the current study was to assess the effects of AET
on general upper limb functions in sedentary people with PD
and healthy adults (HA). Although the exercise program aimed
especially the lower limbs, we relied on the global effect of
aerobic training to drive changes in upper limb function. In order
to infer the CNS mechanisms underlying AET-related changes
in upper-limb functions, we used a fast simple reaction time
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task (FSRTT) based upon the delta-lognormal model of the
kinematic theory (O’Reilly and Plamondon, 2011; Plamondon
et al., 2013a; O’Reilly et al., 2014). Indeed, in a straight line
drawing task to a target, the delta-lognormal model is the
simplest one to use. It can reproduce a given velocity profile
by subtracting two lognormal curves, one representing the
agonist activity toward this target and the other, the antagonist
breaking at this target. We assumed that the kinematic theory
(Plamondon, 1995a,b), with its delta-lognormal model, involving
both agonist and antagonist activations during a simple line
drawing task, would offer an efficient framework not only
to assess the effect of exercise on upper limb function in
PD patients, but also to simultaneously inform us, indirectly,
on the mechanisms underlying its therapeutic impact. For
example, if the AET had an impact on either t0, D1, and D2,
this would mean that the training affected the central motor
controller, whereas if AET had an impact on the µ1, µ2, σ1,
and σ2, this would indicate that the peripheral system would
be involved. Moreover, the present methodology allowed us
to explore the agonist and antagonist systems separately. The
data presented here are part of a larger research program that
investigated the effects of this type of exercise training on
several outcome measures such as cardiorespiratory capacities,
executive functions, and MSL capacity (measured behaviorally
and with functional imaging); the results of which have been
presented elsewhere (Duchesne et al., 2015, 2016). Given that
other types of outcome measures were collected before and after
the intervention, the second objective of the current study was
to investigate the possibility of correlations between exercise-
related changes in upper limb function and other metrics related
to motor symptoms, cardiovascular capacity, executive functions,
and MSL capacity. We hypothesized that: (1) there would be
differences at baseline between PD and their healthy counterparts
regarding the kinematic properties of their agonist and antagonist
neuromuscular systems, (2) these differences would diminish as
a result of training, an effect driven specifically by changes in
the PD group, who were expected to improve the kinematic
parameters of their movements, (3) these improvements in upper
limb movements would correlate with exercise-related changes
in motor symptoms, cardiovascular capacity, executive functions,
and MSL capacity.
MATERIALS AND METHODS
Participants
Eighteen PD patients and 20 HA subjects, between 40 and
80 years of age, took part in the study. They were right-handed,
sedentary [score of 5 or lower on the Jackson’s Questionnaire
(Jackson et al., 1990)], neurologically intact [i.e., score of 24 or
more on the Mini Mental State Evaluation (Folstein et al., 1975)],
or the Montreal Cognitive Assessment (Marinus et al., 2011;
Nasreddine et al., 2005). HA participants were matched with PD
patients at the group level with respect to sex distribution, age,
number of years of education, as well as cognitive and fitness
levels. Exclusion criteria included other neurological disorders,
comorbidities likely to affect gait, smoking, or heart diseases,
and participation to <75% of the AET sessions during the
study. PD patients had to be classified as stage 1 or 2 according
to Hoehn and Yahr’s scale (1967) based upon evaluation of a
certified neurologist (A-LL), and had to score below 35 on motor
functions assessed with the third section of the United PD Rating
Scale (UPDRS III) (Goetz et al., 2008). The target of 75% or
more participation rate in the fitness training program had to be
achieved by all participants to be retained in the analysis. This
study was carried out in accordance with the recommendations
of the research ethics committee’s guidelines of the Research
Center of the “Institut Universitaire de Gériatrie de Montréal,”
which approved the protocol. A written and informed consent
was obtained from participants prior to their inclusion in this
study.
Exercise Intervention Protocol
Prior to engaging in the training regimen, all participants were
cleared by a medical doctor, who analyzed the electrocardiogram
(ECG) at rest and ruled out any cardiac anomalies that could
put participants at risk during exercising. At the same time,
all participants completed a graded exercise test with the
stationary bicycle to obtain their peak oxygen uptake (VO2peak)
(ACMS, 2006). The result at this test was used for personalized
exercise prescription. The duration and frequency of AET was
of 12 weeks, three times per week. Duration of the exercise
sessions started at 20 min and 60% of intensity, and was then
increased by steps of 5 min and 5% of intensity every week,
until participants reached 40 min of training at 80% intensity.
To reach a high-intensity level, bike speed was maintained at 60
revolutions per minute (RPM). As such, to achieve the desired
bike resistance power and adjust intensity level (if needed), the
work intensity was based on power output (Watt), controlling
for subject’s heart rate. In addition, rate of perceived exertion
(Borg scale) (Borg, 1982) was assessed during each training
session. Even if some studies showed good results using FE
(Ridgel et al., 2009, 2012, 2015; Alberts et al., 2011, 2016; Beall
et al., 2013) to improve upper limb functions, we chose to use
VE instead, because from a clinical and practical perspective,
FE devices are not easily accessible to the general public, and
because we wanted to test an easily accessible type of workout
for this population. Trained kinesiologists supervised all training
sessions.
Assessments
Participants were evaluated on a set of outcome measures before
the intervention (at baseline), and immediately after completion
of the 3-month exercise program (post-intervention).
Main Outcome
Kinematic properties of the upper limb movement were assessed
with a target-directed FSRTT using the kinematic theory
(Plamondon et al., 1993, 2003; Plamondon, 1995a,b, 1998). This
task employs an electronic drawing board (a graphic tablet),
an electronic pen (stylus), and an electronic display to present
visual stimuli. The tablet displays a dot in the center (starting
position) and target zones on either side (Figure 1A). On each
trial, participants are required to draw straight lines on the
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graphic tablet by executing simple arm movements in response
to a visual stimulus. Figure 1A depicts the task and its phases:
(1) A LED screen alternating from red to black indicates to
the participants that the system is ready for acquisition. At
this moment, the participant is asked to position the tip of
the stylus on the starting position. (2) Once the stylus hits the
digitizer, the LED screen stops blinking, turns black, and a green
screen appears after a random delay, signaling the subject to
start drawing a straight line toward the target zone as fast as
possible. This delay is exponentially distributed, the parameters
of the corresponding flat hazard distribution have been chosen
such that the delay is between 0 and 10s. Thus, regardless of the
duration the subject has waited for the stimulus, the probability
that it will be emitted during the next millisecond is always the
same (Luce, 1986). During line drawing, and once in the target
zone, the pen has to be in contact with the tablet. (3) Once the
stylus is in the target zone, the participants are required to keep
it immobile and in contact with the tablet for a 3–5 s to allow
for a better delimitation of the movement. After completing a
trial, participants are asked to raise the stylus and wait for the
screen to start alternating from black to red again signaling the
onset of a new trial. Participants are informed that neither the
precision, nor the direction of the movement are important, only
the speed of execution. A speed curve is then obtained for each
line drawn (Figure 1B). Trials in which participants did not reach
the target zone or needed two segments to reach it were not
counted and analyzed. Thirty successful trials, or a maximum of
40 trials, were required of all participants, whichever criterion
was reached first. The mean of each kinematic parameter was
calculated from successful trials and used as dependent variables
(see the section “Extraction of the kinematic parameters of the
movements”).
Secondary Outcomes
As secondary outcomes for the current study, we included
the patient’s motor symptoms evaluation, assessed with the
UPDRS (Goetz et al., 2008), sub-divided in scores for rigidity,
tremor, motor symptoms for the right upper limb (including
the following items: tremor at rest, postural tremor, rigidity of
arm, finger taps, hand movements, rapid alternating movements
of hands) in addition to a total score for this section
of the questionnaire. Participants’ cardiovascular fitness level
(VO2peak) was evaluated using a recumbent bike, either by
a submaximal aerobic test (11 HA, 5 PD) or by a medically
supervised maximal oxygen uptake test (9 HA, 14 PD). Mood
was also evaluated using the Beck Depression Inventory (Beck
et al., 1961) and the Beck Anxiety Inventory (Beck et al.,
1988). The Stroop Test (naming, reading, interference) (Stroop,
1935) and the Trail Making Test (TMT A and B) (Sánchez-
Cubillo et al., 2009) were used to evaluate inhibition and
cognitive flexibility, respectively, two components of executive
neuropsychological functions. In addition, participants’ MSL
capacity was evaluated behaviorally using an implicit serial
reaction time (RT) task performed during functional MRI
acquisition. For more details regarding those evaluations, please
refer to our previous published work (Duchesne et al., 2015,
2016).
Extraction of the Kinematic Parameters
of the Movements
Participants’ trials were used to extract several kinematic
parameters of the movement based on the kinematic model
(Figure 1C). Reconstruction of the velocity profile using
two lognormal models was used to reveal the agonist and
antagonist components of the profile. The upper curve (solid
line) represents a measure of the agonist activity, which
corresponds to the velocity of the pen tip toward its target. By
contrast, the lower curve (dotted line) depicts the antagonist
activity, which has a direct opposite contribution and is mainly
used to break the motion, although it can also be useful in
stabilizing the movement and in increasing its precision. The
obtained velocity profile obeys the following delta-lognormal law
(Plamondon et al., 1993, 2003; Plamondon, 1995a,b, 1998):
υ(t) = D11(t; t0,µ1, σ21)− D22(t; t0,µ2, σ22),
where
(t; t0,µi, σ2i ) =
1
σi
√
2pi(t − t0)
exp−
(
(ln(t − t0)− µi)2
2σ2i
)
,
and where t0 represents the time occurrence of the simultaneous
input commands D1 and D2 to the neuromuscular system. The
time between the occurrence of the stimulus (t = 0) and t0 is,
in fact, the period needed for the perception of the stimulus
and the command preparation. The delay between the stimulus
onset (t = 0) and the beginning of the movement (beginning
of the velocity increase) corresponds to the classical RT. The
time between t0 and the RT corresponds to the command
propagation time. In the upper curve, the area under the curve
corresponds exactly to the agonist response (D1), while the µ1
and the σ1 represent, respectively, the time delay and the response
spread of the agonist activation on a logarithmic scale. The
equivalent is presented with the lower curve for the antagonist
response (D2, µ2, σ2). In other words, t0, D1, and D2 reflect
command processes, often referred to the action plan, in terms of
amplitude and time occurrence, while µ1, σ1, µ2, and σ2 reflect
the distributed timing properties of the system. The elapsed time
(ET) corresponds to the delay between the moment where the
visual stimulus is sent until the immobilization of the stylus on
the digitizer, while the moment where the movement is started
(beginning of the curve), until the immobilization of the stylus
on the tablet is considered as the movement time (MT). Signal-
to-noise ratio (SNR) between the original and the reconstructed
velocity profile can be considered like a cue of the reconstruction’s
quality. As suggested in O’Reilly et al. (2013), a SNR of 20 dB
minimum is required to use the trial in the analysis, without that,
the reconstruction was considered of too low quality. Also, trials
with a negative t0 were rejected from analyzes. This situation may
occur when the protocol is not respected in a given trial and
a movement is anticipated, that is the commands are initiated
before the onset of the stimulus. This might also seldom happen
when the parameter extraction algorithm fails. Indeed, t0 is
computed from the curve fitting process using a seven parameter
optimization algorithm that minimizes the error between the
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original velocity curve and the reconstructed one, using the delta-
lognormal equation. Given that there is no guarantee that the
process will always lead to a global optimum, there are instances
where the algorithm might get trapped in a local inconsistent
minimum with a negative t0.
Statistical Analysis
As our main interest is to verify whether each group reacted
to the 3-month AET, we first carried out simple repeated-
measures ANOVA, separately for each group. The dependent
variables were the kinematic parameters and the independent
variable was the time of the assessment (pre- vs. post-AET).
Whenever we observed significant changes in a single group,
a repeated-measure ANCOVA model (the same dependent
variables, but with group and time of assessment as independent
variables) was used to test the effect of AET on primary
and secondary outcomes in PD participants compared to HA
subjects. Given that there were significant differences between
the groups in terms of depression level and age at baseline, we
used these variables as covariates in the model to statistically
control for their effect when assessing group differences. The
ANCOVA aimed to test for group differences across assessments
(group ∗ assessment interaction), as well as the effect of training
within each group after AET, for all kinematic movement
parameters. In order to account for the effect of multiple
comparisons, the statistical significance was adjusted using the
Bonferroni method. Paired t-test was used to evaluate AET-
related changes in UPDRS subscores in PD participants alone.
In addition, the associations between exercise-related changes
in upper-limb functioning, cardiovascular capacity, executive
functions, and MSL in PD patients were tested using Pearson’s
partial correlation (controlling for age and depression level).
All results were expressed as means ± standard deviations for
descriptive statistics. Analyses were conducted using SPSS 21.0
(IBM, Armonk, NY, United States: IBM Corp.). The level of
statistical significance for all tests was set at p< 0.05.
RESULTS
Forty-four participants (21 PD patients and 23 HA) were eligible
after the completion of the first evaluation. Two HA decided
to withdraw from the project prior to commencing the AET
regimen, for personal reasons. Two participants (1 HA and 1
PD) did not complete the program because of medical conditions
external to the research project. One PD patient completed the
AET, but was excluded from analysis because of unusually low
levels of physical and cognitive performances (outlier: mean > 2
SD). Another PD patient was excluded from the analyses for
technical reasons given that his drawing trials were not saved
during one of the evaluations. A total of 38 persons (18 PD
patients and 20 HA) were thus included in the final analysis.
Demographic characteristics and initial values of the study
participants are described in Table 1. The 3-month AET did
not permit to observe any change in the UPDRS III in PD
participants, whether in total, at the level of tremor, rigidity, or
the right upper limb (Table 2).
We observed significant difference between PD and HA
groups at baseline in regards to three variables: D2 (p < 0.05),
ET (p< 0.05), and MT (p< 0.01), suggesting that PD individuals
had a larger antagonist response, a longer ET between the visual
stimulus and the end of the movement, and longer time of
displacement of the stylus before the exercise training program
began.
Following the 12-week AET, the repeated measures ANOVA
revealed that PD participants showed significant decreases
of the D1 (F1,17 = 8.916, p < 0.01), D2 (F1,17 = 5.039,
p < 0.05), and σ2 (F1,17 = 6.553, p < 0.05), the agonist
command, the antagonist command, and its response spread,
respectively. The mixed ANCOVA model revealed a significant
group ∗ session interaction effect for D1 (F1,34 = 8.679, partial
R2 = 0.203, p < 0.01) and σ2 (F1,34 = 5.359, partial R2 = 0.136,
p < 0.05) (Table 2), suggesting a significant change for these two
parameters only in PD patients following AET (Figure 2). While
differences were observed at baseline for D2, ET, and MT, the
groups did not differ significantly in post-AET comparisons for
D2 and ET (Figure 3).
As reported previously by our research group (Duchesne
et al., 2015, 2016), significant between-sessions differences
were found in both groups for outcomes related to aerobic
capacity (VO2 peak), MSL capacity, and cognitive inhibition (all
p < 0.05), indicating that the training improved participants’
fitness, procedural learning, and cognitive inhibition, regardless
of the health status (see Supplementary Material, Nadeau et al.,
2017, AET-related changes in various domains). However, in
the current study, we tested for correlations between these
variables and kinematic parameters that showed significant AET-
related changes (D1, D2, σ2, MT), among PD participants.
We observed a significant association between the change in
cognitive inhibition and σ2 (r = −0.560, p < 0.05, df = 14),
as well as between AET-related change in inhibition and the
change in MT (r = −0.531, p < 0.05, df = 14). These
results indicate that an increase in response spread of the
antagonist component or in MT is associated with a decrease
TABLE 1 | Demographic data.
Characteristics HA PD Group
differences
Age (years) 64 ± 8.19 59 ± 7.11 p = 0.06
Ratio men/women 8/12 13/6 p = 0.07
Education (years) 15.7 ± 2.36 15.05 ± 2.78 p = 0.43
Cognition (MMSE/MoCA) 29.18 ± 1.25 28.4 ± 1.34 p = 0.28
29.56 ± 1.51 27.21 ± 1.85 p = 0.08
Depression (BDI) 4.8 ± 4.5 10.5 ± 8.3 p < 0.01
Anxiety (BAI) 2.1 ± 2.7 8.6 ± 9.4 p < 0.01
Inhibition (Stroop, in s) 115.4 ± 4.7 128.5 ± 6.7 p = 0.12
Flexibility (TMT, in s) 75.0 ± 6.4 85.5 ± 10.5 p = 0.39
UPDRS III N/A 21.84 ± 6.16 N/A
Duration of disease (years) N/A 8.1 ± 9.12 N/A
H&Y N/A 2.1 ± 0.2 N/A
Means ± SD. HA, healthy adults; PD, Parkinson’s diseases patients; N/A, non-
applicable; s, seconds.
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TABLE 2 | Kinetic parameters of the fast simple reaction time task and motor symptoms examination.
Kinematic variables HA PD Statistical significance
Pre-AET Post-AET Pre-AET] Post-AET Interaction AET Group
SNR 25.6 ± 4.3 26.3 ± 4.7 24.1 ± 3.9 23.5 ± 2.7 0.151 0.503 0.116
Number of trials 23.4 ± 5.2 21.7 ± 7.2 17.8 ± 8.1 20.6 ± 5.3 0.119 0.606 0.442
t0 0.17 ± 0.08 0.17 ± 0.08 0.15 ± 0.07 0.16 ± 0.06 0.555 0.306 0.706
D1 119.4 ± 11.2 122.8 ± 9.9 126.6 ± 15.8 115.1 ± 7.3† 0.006∗ 0.719 0.965
µ1 −1.17 ± 0.34 −1.19 ± 0.42 −0.86 ± 0.37 −0.95 ± 0.37 0.675 0.283 0.055
σ1 0.29 ± 0.06 0.27 ± 0.05 0.28 ± 0.05 0.28 ± 0.05 0.957 0.207 0.934
D2 22.1 ± 6.5 22.6 ± 6.9 30.8 ± 14.1 22.8 ± 5.0† 0.052 0.683 0.064
µ2 −0.81 ± 0.32 −0.84 ± 0.39 −0.57 ± 0.33 −0.64 ± 0.32 0.824 0.324 0.128
σ2 0.12 ± 0.02 0.11 ± 0.02 0.13 ± 0.03 0.11 ± 0.01† 0.027∗ 0.236 0.226
ET 0.72 ± 0.15 0.70 ± 0.19 0.88 ± 0.23 0.83 ± 0.19 0.489 0.490 0.027∗
RT 0.33 ± 0.10 0.34 ± 0.13 0.37 ± 0.11 0.37 ± 0.10 0.487 0.064 0.512
MT 0.35 ± 0.10 0.33 ± 0.10 0.48 ± 0.17 0.42 ± 0.12† 0.133 0.671 0.007∗
UPDRS III
Tremor N/A N/A 1.08 ± 1.26 1.08 ± 1.56 1.000
Rigidity N/A N/A 4.72 ± 2.65 3.81 ± 2.43 0.124
Right UL N/A N/A 4.61 ± 1.53 4.58 ± 1.78 0.923
Total N/A N/A 21.92 ± 6.32 21.53 ± 6.38 0.765
Means ± SD. †A significant within-group difference from baseline. ∗A significant effect for interaction or mean effects. HA, healthy adults; PD, Parkinson’s disease patients;
AET, aerobic exercise training; SNR, signal-to-noise ratio (in decibels); number of trials, number of successful trials; t0, time occurrence of the input commands to the
neuromuscular system; D1, agonist component; µ1, time delay of D1; σ 1, response spread of D1; D2, antagonist component; µ2, time delay of D2; σ 2, response spread
of D2; ET, time between visual stimulus and the immobilization of the stylus; RT, reaction time; MT, movement time; UL, upper limb, includes the following items: tremor
at rest, postural tremor, rigidity of arm, finger taps, hand movements, rapid alternating movements of hands.
in inhibition effect. No correlation was observed between any
of the kinematic parameters and the patients’ aerobic or MSL
capacities.
DISCUSSION
In the current study, we investigated the effects of an AET
regimen using stationary bicycling on kinematic parameters of an
arm movement in sedentary HA and in PD patients. As reported
previously by our group (Duchesne et al., 2015, 2016), such
training regimen improved cardiovascular capacity, executive
functions, and motor learning capacities in both groups. Here,
we report that AET also had a significant positive impact on the
capacity to draw lines in a more efficiency way, in PD patients,
indicating an improvement in the upper limb motor function.
Specifically, after AET there was a significant decrease of the
antagonist response of the movement (D2), an amelioration that
can be interpreted as an improvement in the control of the motor
command in PD patients. Other AET-related changes included
a better response spread of the antagonist activation (σ2), which
may reflect a more global modification of the CNS in improving
its response time. The significant improvement in MT in the
context of no change in the RT also demonstrates AET-related
improvements in the capacity to execute a faster movement, while
the time needed from the brain to process the information of the
visual stimulus remained the same in PD patients. Although we
did not observe any changes in motor symptoms (UPDRS III),
this last result suggests that the improvements measured while
drawing lines are not due to a decrease in rigidity, for example. By
contrast to the changes observed in the PD group, no significant
AET-related changes in the kinematic parameters were observed
in the HA group.
Initial group differences for ET and D2 variables disappeared
after AET, suggesting an effect of “normalization” due to
improvements in PD patients. For the MT, even if there was
a significant AET-related change in PD patients, the difference
between the two groups was still present after AET. To our
knowledge, this is the first time a “normalization” effect is
reported following AET in PD patients in regards to the upper
limb motor function.
We found a significant negative relationship between changes
in cognitive inhibition of PD participants and their change
in the MT or response spread of the antagonist activation
(σ2), indicating that individuals who improved on one variable
showed a decrease in the other after AET. Although conjectural,
these results suggest that in this specific population, there
may be a trade-off between improving motor function and
executive function. It may also indicate the presence of two
clinical sub-populations in our sample, a mixture of patients
who are more impaired on either executive or motor functions
hence responding differently to the intervention and making
the correlation spurious. Further studies should explore this
issue.
To date, studies on physical exercise training have proposed
several action mechanisms underlying this type of intervention.
The simplest one is that increase of heart rate and blood
pressure during exercise could help to increase effectiveness
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FIGURE 2 | Agonist and antagonist responses before and after AET for PD and HA groups. AET, aerobic exercise training; PD, Parkinson’s disease patients; HA,
healthy adults.
FIGURE 3 | Normalization of antagonist parameters in PD group after AET.
AET, aerobic exercise training; PD, Parkinson’s disease patients, HA, healthy
adults; D2, antagonist component; σ2, response spread of D2.
of PD medication by making it more easily pass the blood–
brain barrier (Speelman et al., 2011). Also, some studies have
reported an increase in brain-derived neurotrophic factors
(BDNFs) and glia cell line-derived neurotrophic factor (GDNF),
neurotrophins known to regulate survival and activity of
dopaminergic neurons, following short bouts of aerobic exercise
in PD patients (Frazzitta et al., 2014; Zoladz et al., 2014; Marusiak
et al., 2015). Moreover, Marusiak et al. (2015) reported that
this increase in BDNF levels correlated with improvements
in PD rigidity. Another proposed action mechanism has
been related to neurotransmitters, as that progressive aerobic
exercise could lead to an increase in dopamine D2 receptor
density within the regional boundaries of the dorsal striatum
[observed with PET imaging (Fisher et al., 2013)]. Similarly,
there is evidence for an increase in corticomotor excitability
(observed via transcranial magnetic stimulation) in Parkinsonian
individuals (Fisher et al., 2008). It is important to highlight
the fact that our participants used primarily the lower limbs
during AET; yet we observed changes in the upper limb.
This would suggest that functional changes in corticospinal
pathways may occur at multiple levels, not only at those directly
involved in generating and controlling the limbs performing the
movements. In support of such mechanisms are the findings
of a work performed by Zhou et al. (2017) that demonstrate
changes in the motor-evoked potentials in the lower limb in
neurologically intact individuals and patients with incomplete
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spinal cord injury following arm cycling alone or simultaneous
arm and leg cycling, respectively. Our study adds to this
body of knowledge, by providing evidence that AET can
improve the synergistic action of an agonist and antagonist
neuromuscular networks in PD. Whether this improvement
in motor control is achieved via one or some of these
neurophysiological mechanisms remains to be explored in future
research.
A third possible mechanism of action could be that AET
may lead directly to structural and/or functional changes in the
brain. Indeed, many neuroimaging studies have already reported
differences in gray and white matter between HA and PD subjects
(Lehéricy et al., 2012; Meijer et al., 2013; Agosta et al., 2016; Al-
Radaideh and Rababah, 2016), as well as in functional activity
at rest or during various tasks (Mallol et al., 2007; Sharman
et al., 2012; Caproni et al., 2013; Skidmore et al., 2013; Nigro
et al., 2016). However, to date, only one study reported the
effect of exercise training on the neural correlates of MSL in PD
(Duchesne et al., 2016).
Contrary to other studies using FE to improve upper limb,
we chose to use VE instead. FE is described as an aerobic
exercise in which the rate is augmented mechanically to assist
the participant, hence allowing the achievement and maintenance
of an exercise rate greater than the preferred voluntary rate of
exercise (VE). Consequently, it has been hypothesized that the
magnitude of intrinsic feedback provided in FE could permit the
release of a greater amount of dopamine than VE, which could
then have a greater positive impact on the brain structure and
function in PD (Alberts et al., 2011). In fact, it has been proposed
that lower-extremity FE could produce global improvements in
motor symptoms using the same pathways through which anti-
PD medication acts to produce symptomatic relief in individuals
with PD (Alberts et al., 2016). For this reason, it has also
been suggested that FE could be a better way to exercise for
people affected by PD. However, from a clinical and practical
perspective, FE devices are not easily accessible to the general
public, including people suffering from PD. Furthermore, given
that our study shows that there are significant beneficial effects
when using VE, we thus believe that this latter type of training is
more feasible in clinical settings.
The fact that we observed improvements in kinematic
parameters, but not in the UPDRS scores, after AET suggests
that our task using the delta-lognormal model (Plamondon et al.,
1993, 2003; Plamondon, 1995a,b, 1998) may be a more sensitive
mean to assess changes in motor function (and indirectly,
motor symptoms) following treatment in PD. Even though
accelerometers and gyroscopes could be used to record three-
dimensional motions and to quantify more objectively tremor
and bradykinesia during the different tasks composing the motor
examination of the UPDRS (Heldman et al., 2014), such a
setup does not offer any insight into the neurophysiological
mechanisms underlying the motor symptoms (i.e., agonist and
antagonist muscle activity during motor task performance).
The original contribution of the current study is thus the
use of a relatively simple kinematic task, which can be easily
performed by PD patients and, most importantly, does offer
an indirect and objective clinical measure of the state of the
global neurophysiological mechanisms involved in controlling
the upper limb. Indeed, it must be remembered that the
lognormal impulse response predicted by the kinematic theory
is the optimal function describing the neuromuscular system
of human subjects in perfect control of their movements
(Djioua and Plamondon, 2010). As a person get old, he/she
will depart from this ideal behavior more or less severely,
depending on his/her health status (Plamondon et al., 2013b).
In this context, the SNR can be seen as an objective parameter
that characterizes the global motor behavior of a subject. The
higher it is the better is the motor control. Moreover, the
delta-lognormal model proposes a complementary and new
window to analyze and interpret a movement kinematics in
terms of agonist (D1) and antagonist (D2) input commands,
which reflects the intention of a subject, as D1−D2 is equal to
the physical distance covered by a given movement. Similarly,
the occurrence of these commands at t0 has been shown to
be directly correlated to a specific ERP potential occurring
at t0 (O’Reilly et al., 2013). Similarly, the timing parameters
µ and σ indirectly reflect the muscle coupling through the
proportionality of their cumulative time delays, as observed
via EMG data (Plamondon et al., 2013a). In other words,
reconstructing each velocity profile with the delta lognormal
model, a neuroscientist get access to physiologically meaningful
global parameters describing the status of the agonist and
antagonist neuromuscular system of a subject, can monitor its
time evolution and estimate if he or she is improving, stays stable,
or deteriorates.
One limitation of the current study was the lack of a PD
control group for the type and intensity of exercise (e.g., a
PD group undertaking another type of training regimen). Also,
having more than the two pre- and post-AET assessments would
have allowed the mapping of the trajectory of changes during
training. Another limitation stems from the use of a mathematical
model (kinematic theory) to infer the neurophysiological changes
in the motor system; even though this model has been found
to have some physiological plausibility, supported previously
with EEG and EMG, it remains nevertheless an indirect
assessment of these mechanisms. EEG or EMG would have to
be used in future research to corroborate the findings of the
present study. Despite these constraints, however, our findings
indicate that using VE and a typical stationary bicycle can
still lead to great improvements in the upper limb movement
fluidity, in addition to aerobic capacity, executive function,
MSL, and in gait. Finally, we believe that our study results
contribute to the field and may inspire future research about
how exercise could help to improve activities of daily living
relying on the motor function of the upper limb in people
with PD.
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